Trust Company of Vermont’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-50
| Closed | -$1K | – | 879 |
|
|
2022
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 940 |
|
|
2022
Q2 | $1K | Buy |
+50
| New | +$1.44K | ﹤0.01% | 869 |
|
|
2022
Q1 | – | Sell |
-50
| Closed | -$2K | – | 341 |
|
|
2021
Q4 | $2K | Buy |
+50
| New | +$1.62K | ﹤0.01% | 768 |
|
|
2021
Q3 | – | Sell |
-50
| Closed | -$2K | – | 331 |
|
|
2021
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 741 |
|
|
2021
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 714 |
|
|
2020
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 712 |
|
|
2020
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 697 |
|
|
2020
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 740 |
|
|
2020
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 840 |
|
|
2019
Q4 | $2K | Sell |
50
-28
| -36% | -$1.01K | ﹤0.01% | 870 |
|
|
2019
Q3 | $3K | Hold |
78
| – | – | ﹤0.01% | 871 |
|
|
2019
Q2 | $3K | Buy |
78
+28
| +56% | +$1.2K | ﹤0.01% | 884 |
|
|
2019
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 898 |
|
|
2018
Q4 | $2K | Sell |
50
-133
| -73% | -$6.97K | ﹤0.01% | 916 |
|
|
2018
Q3 | $13K | Sell |
183
-24
| -12% | -$1.54K | ﹤0.01% | 755 |
|
|
2018
Q2 | $12K | Hold |
207
| – | – | ﹤0.01% | 788 |
|
|
2018
Q1 | $9K | Buy |
207
+18
| +10% | +$855 | ﹤0.01% | 762 |
|
|
2017
Q4 | $8K | Sell |
189
-62
| -25% | -$2.85K | ﹤0.01% | 788 |
|
|
2017
Q3 | $11K | Buy |
251
+46
| +22% | +$1.96K | ﹤0.01% | 716 |
|
|
2017
Q2 | $8K | Hold |
205
| – | – | ﹤0.01% | 759 |
|
|
2017
Q1 | $8K | Sell |
205
-3
| -1% | -$117 | ﹤0.01% | 738 |
|
|
2016
Q4 | $7K | Hold |
208
| – | – | ﹤0.01% | 737 |
|
|
2016
Q3 | $7K | Sell |
208
-50
| -19% | -$1.75K | ﹤0.01% | 702 |
|
|
2016
Q2 | $8K | Sell |
258
-575
| -69% | -$17.6K | ﹤0.01% | 634 |
|
|
2016
Q1 | $24K | Sell |
833
-87
| -9% | -$2.32K | ﹤0.01% | 489 |
|
|
2015
Q4 | $30K | Sell |
920
-169
| -16% | -$5.25K | ﹤0.01% | 465 |
|
|
2015
Q3 | $31K | Sell |
1,089
-127
| -10% | -$4.43K | ﹤0.01% | 456 |
|
|
2015
Q2 | $49K | Sell |
1,216
-124
| -9% | -$5.57K | 0.01% | 405 |
|
|
2015
Q1 | $65K | Sell |
1,340
-158
| -11% | -$7.32K | 0.01% | 365 |
|
|
2014
Q4 | $69K | Buy |
+1,498
| New | +$58.9K | 0.01% | 349 |
|
Other funds holding AVNS
RC
PIM
WHG
Trust Company of Vermont's AVNS Position: Q4 2022 in Review
Trust Company of Vermont sold out of Avanos Medical (AVNS) in Q4 2022, closing a stake of 50 shares — an estimated $1K sold.
Trust Company of Vermont first reported a position in AVNS in Q4 2014 and held it in 30 quarters. The position peaked at $69K in Q4 2014. 288 funds tracked by Wall St. Rank hold AVNS as of Q4 2022.
- Trust Company of Vermont reported no remaining Avanos Medical position as of Q4 2022 after selling out during the quarter.
- Trust Company of Vermont sold 50 Avanos Medical shares in Q4 2022, an estimated $1K.
- Trust Company of Vermont first reported a position in Avanos Medical in Q4 2014 and held it in 30 quarters.
- Trust Company of Vermont's Avanos Medical position peaked at $69K in Q4 2014.
- 288 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2022.
Based on Trust Company of Vermont's 13F filing for Q4 2022, filed 9 Feb 2023.